| Popis: |
Introduction: The SARS-CoV-2 virus, responsible for COVID-19, was declared in 2020 as a pandemic by the WHO. Due to the new scientific discoveries, correlations between SARS- CoV-2 and neurological manifestations were established. Among them, the Guillain-Barre Syndrome (GBS) is a concern, since it culminates in patient debility. The study has the relevance of knowing the impacts and complications of COVID 19 associated with GBS. In this context, the study presents the guiding question: What are the complications of Covid 19 with GBS? Objectives: To review the literature, highlighting the relationship between COVID- 19 and neurological complications, mainly GBS. Methodology: The study is a literature review, using the PubMed database. The descriptors “Guillain Barre” and “Covid 19” and “Complications” from the last year were used and 56 articles (free, of the type Books and documents; Clinical trial; Controlled and randomized testing; and Analysis) were selected. Results: The studies have shown the existence of an association between GBS and SARS-CoV-2. GBS associated with Covid-19 resulted in manifestations such as facial weakness, limb paresthesia, pain and weakness in the extremities with areflexia. The onset time of neurological symptoms was 6.5 to 11 days after respiratory or systemic characteristics. The liquor is normocellular, hyperproteinorchy, absence of anti-ganglioside antibodies and no SARS-CoV2 was detected in the sample, showing that there is no direct root infection or viral replication. Conclusion: It is concluded that there are neurological complications associated with COVID- 19, emphasizing the GBS, which highlights the need for measures of initial interventions. |
